The Unona Pharmaceutical Holding Seeks 280 Million Euro of Investment

31.03.2009 — News

THE SVERDLOVSK OBLAST.

Aleksandr Petrov, the Director General of the Unona Pharmaceutical Holding Company have conducted negotiations with the representatives of the Japan Business Club in Moscow. He has presented a number of investment projects in the area of high tech production of pharmaceutical glassware, nanotechnologies, and genetic engineering. For instance, insulin production at the OOO Zavod Medsintez plant has been suggested to Japanese corporations as an investment avenue. The plant's capacity can fully satisfy Russia's demand for this vital drug. RusBusinessNews was informed that the total net profit of all investment projects of the company, assessed at 280 million Euro, should reach 22 billion roubles by 2020. Unona has previously contacted businessmen from Denmark and Great Britain with the same offer.